- Home
- BGLC vs MTEM Comparison
BGLC vs MTEM Comparison
Compare BGLC & MTEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- MTEM
- Stock Information
- Founded
- BGLC 2017
- MTEM 2001
- Country
- BGLC Malaysia
- MTEM United States
- Employees
- BGLC N/A
- MTEM N/A
- Industry
- BGLC Medical Specialities
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BGLC Health Care
- MTEM Health Care
- Exchange
- BGLC Nasdaq
- MTEM Nasdaq
- Market Cap
- BGLC 7.6M
- MTEM 9.7M
- IPO Year
- BGLC N/A
- MTEM N/A
- Fundamental
- Price
- BGLC $0.37
- MTEM $0.75
- Analyst Decision
- BGLC
- MTEM
- Analyst Count
- BGLC 0
- MTEM 0
- Target Price
- BGLC N/A
- MTEM N/A
- AVG Volume (30 Days)
- BGLC 117.9K
- MTEM 13.3M
- Earning Date
- BGLC 11-20-2024
- MTEM 11-11-2024
- Dividend Yield
- BGLC N/A
- MTEM N/A
- EPS Growth
- BGLC N/A
- MTEM N/A
- EPS
- BGLC N/A
- MTEM N/A
- Revenue
- BGLC $9,183,168.00
- MTEM $25,470,000.00
- Revenue This Year
- BGLC N/A
- MTEM N/A
- Revenue Next Year
- BGLC N/A
- MTEM N/A
- P/E Ratio
- BGLC N/A
- MTEM N/A
- Revenue Growth
- BGLC N/A
- MTEM N/A
- 52 Week Low
- BGLC $0.31
- MTEM $0.30
- 52 Week High
- BGLC $3.39
- MTEM $6.48
- Technical
- Relative Strength Index (RSI)
- BGLC 32.80
- MTEM 39.63
- Support Level
- BGLC $0.38
- MTEM $0.31
- Resistance Level
- BGLC $0.49
- MTEM $1.34
- Average True Range (ATR)
- BGLC 0.02
- MTEM 0.14
- MACD
- BGLC -0.01
- MTEM -0.06
- Stochastic Oscillator
- BGLC 5.94
- MTEM 38.14
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.